CSI Market
Sign In | Register

Viveve Medical Inc (VIVE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VIVE Annual Cash Flow →
This page allows investors to follow Viveve Medical Inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
9 Months 		(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Operating Activities
Income-16.66
Depreciation & amortization0.57
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.01
Increase (Decrease) in Inventories0.12
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.02
Share-based Compensation2.74
Income (Loss) from Equity Method Investments0.12
Financial Instruments and Foreign Currency Transaction0.00
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax-
Change In Fair Value Of Warrant Liabilities-
Change In Fair Value Of Convertible Notes-
Restricted Stock Awards Granted To Consultant-
Issuance Of Restricted Common Shares-
Amortization Of Operating Lease Right Of Use Asset And Accretion Of Operating Lease Liabilities0.00
Changes In Assets And Liabilities-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.32
Increase (Decrease) in Accounts Payable-0.37
Increase (Decrease) in Accrued Liabilities1.01
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.17
Other Working Capital-1.02
Other Noncash Expense0.50
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.46
Discontinued operations0.00
Net Cash flow from Operating Activities-13.01
Investing Activities
Capital Expenditures-0.30
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.30
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.05
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Convertible Notes And Warrants-
Payments For Reserve Stock Split Cancellation And Payout Of Fractional Shares-
Payments Of Warrant Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.05
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-13.31
Total Cash Flow-13.26
4 historic quarters locked

Sign in to unlock the full Viveve Medical Inc cash flow history.

Sign In Create Free Account

About Viveve Medical Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-22-026899

Figures are derived from filed reports and may be restated. Historical data is subject to revision.